{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-227023","form_type":"8-K","ticker":"HSCS","cik":"0001468492","company_name":"HeartSciences Inc.","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.467315+00:00","generated_at":"2026-05-17T05:04:20.359786+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"HeartSciences extends loan maturity to 2026, raises $6.7M in Reg A, exchanges $2.06M debt for equity","bullets":["Loan maturity extended to Sept 30, 2026; accrued interest payment structure amended.","Raised $6.7M gross from Reg A offering of 1,912,383 Units as of Oct 1, 2025.","Converted 1,331,044 Series D Preferred shares into common stock under Reg A.","Exchanged $2.06M principal + $45K accrued interest for 597,578 common shares.","Common shares outstanding total 3,069,635 as of Oct 1, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-227023","json":"https://secwatch.observer/filing/0001193125-25-227023.json","markdown":"https://secwatch.observer/filing/0001193125-25-227023.md","text":"https://secwatch.observer/filing/0001193125-25-227023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468492/000119312525227023/0001193125-25-227023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468492/000119312525227023/hscs-20250926.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:04:20.359786+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5811c81cb5706a764c6a509638be75eb472e87ec","claim":"HeartSciences Inc. amended loan of $500,000 with Front Range Ventures LLC at 12% per annum maturing September 30, 2026.","evidence_excerpt":"Loan Agreement, the No. 1 Amendment, the No. 2 Amendment, the No. 3 Amendment, the No. 4 Amendment and the No. 5 Amendment, the “Loan Agreement”), for the Company to borrow $500,000 from Front Range Ventures LLC (“FRV”) as evidenced by a secured, non-convertible promissory note, dated April 24, 2020, as amended by the Amended and Restated Secured Promissory","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468492/000119312525227023/0001193125-25-227023-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$500,000"},{"label":"Counterparty","value":"Front Range Ventures LLC"},{"label":"Rate","value":"12% per annum"},{"label":"Maturity","value":"September 30, 2026"},{"label":"Event","value":"amendment"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}